Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 10, 2012, Pages 1165-1173

  Hammar, Oskar ^a   Ohlsson, Bodil ^a   Veress, Béla ^a   Alm, Ragnar ^a   Fredrikson, Gunilla Nordin ^a   Montgomery, Agneta ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic intestinal pseudo obstruction (CIPO); Dysmotility; Enteric dysmotility (ED); Full thickness biopsy; Gonadotropin relasing hormone (GnRH); In vitro fertilization (IVF)

Indexed keywords

GONADORELIN; GONADORELIN ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; DIVERTICULOSIS; ENDOMETRIOSIS; FEMALE; GANGLION; GASTROINTESTINAL MOTILITY DISORDER; HORMONE BLOOD LEVEL; HUMAN; IMMUNOREACTIVITY; INTESTINE PSEUDOOBSTRUCTION; MALE; MYENTERIC PLEXUS; NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIBODIES; BIOPSY; CARCINOMA; CHRONIC DISEASE; DIVERTICULUM; ENTERIC NERVOUS SYSTEM; FEMALE; FERTILIZATION IN VITRO; GASTROINTESTINAL MOTILITY; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; INTESTINAL PSEUDO-OBSTRUCTION; INTESTINES; MALE; PRECIPITATING FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84866599691     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.706826     Document Type: Article

References (41)

1. De Giorgio R, Sarnelli G, Corinaldesi R, Stanghellini V. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004;53:1549-52. (Pubitemid 39434089)
2. Stanghellini V, Camilleri M, Malagelada Jr. Chronic idiopathic intestinal pseudo-obstruction: Clinical and intestinal manometric findings. Gut 1987;28:5-12. (Pubitemid 17231539)
3. Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997;41:675-81. (Pubitemid 27496149)
4. Wingate D, Hongo M, Kellow J, Lindberg G, Smout A. Disorders of gastrointestinal motility: Towards a new classification. J Gastroenterol Hepatol 2002;17(Suppl):S1-14.
5. Stanghellini V, Cogliandro RF, de Giorgio R, Barbara G, Salvioli B, Corinaldesi R. Chronic intestinal pseudo-obstruction: Manifestations, natural history and management. Neurogastroenterol Motil 2007;19:440-52. (Pubitemid 46905392)
6. Ohlsson B, Veress B, Janciauskiene S, Montgomery A, Haglund M, Wallmark A. Chronic intestinal pseudoobstruction due to buserelin-induced formation of anti- GnRH antibodies. Gastroenterology 2007;132:45-51. (Pubitemid 46108749)
7. Ohlsson B, Ekblad E, Veress B, Montgomery A, Janciauskiene S. Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction. BMC Gastroenterol 2010;10:48.
8. Huang W, Yao B, Sun L, Pu R, Wang L, Zhang R. Immunohistochemical and in situ hybridization studies of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract. Life Sci 2001;68:1727-34.
9. Chen L, He HX, Sun XD, Zhao J, Liu LH, Huang WQ, et al. Expression of gonadotropin-releasing hormone receptor and effect of gonadotropin-releasing hormone analogue on proliferation of cultured gastric smooth muscle cells of rats. World J Gastroenterol 2004;10:1780-4. (Pubitemid 38931204)
10. Ohlsson B, Sjoberg K, Alm R, Fredrikson GN. Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum. Neurogastroenterol Motil 2011;23:1000-6.
11. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut 2001;49:145-51. (Pubitemid 32601892)
12. Hanson M, Lilja B. Gastric emptying in smokers. Scand J Gastroenterol 1987;22:1102-4. (Pubitemid 17157005)
13. Abrahamsson H, Antov S, Bosaeus I. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal x-ray in healthy subjects and constipated patients. Scand J Gastroenterol Suppl 1988;152:72-80. (Pubitemid 19050865)
14. Knowles CH, De Giorgio R, Kapur RP, Bruder E, Farrugia G, Geboes K, et al. The London classification of gastrointestinal neuromuscular pathology: Report on behalf of the Gastro 2009 International Working Group. Gut 2010;59: 882-7.
15. Lindberg G, Tornblom H, Iwarzon M, Nyberg B, Martin JE, Veress B. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut 2009;58: 1084-90.
16. Knowles CH, Veress B, Kapur RP, Wedel T, Farrugia G, Vanderwinden JM, et al. Quantitation of cellular components of the enteric nervous system in the normal human gastrointestinal tract-report on behalf of the Gastro 2009 International Working Group. Neurogastroenterol Motil 2011;23: 115-24.
17. Tornblom H, Lindberg G, Nyberg B, Veress B. Full- thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-9. (Pubitemid 35408321)
18. Hazum E, Conn PM. Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor. Endocr Rev 1988;9:379-86.
19. Naor Z. Signaling by G-protein-coupled receptor (GPCR): Studies on the GnRH receptor. Front Neuroendocrinol 2009;30:10-29.
20. Gama P, Alvares EP. Localization of luteinizing-hormone releasing hormone binding sites in the gastric mucosa of suckling rats. Anat Rec 2001;264:43-50. (Pubitemid 32800521)
21. Soldani G, Del Tacca M, Bambini G, Polloni A, Bernardini C, Martinotti E, et al. Effects of gonadotropinreleasing hormone (GnRH) on gastric secretion and gastrin release in the dog. J Endocrinol Invest 1982;5:393-6. (Pubitemid 13117914)
22. Chen L, Sun XD, Zhao J, Yang AG, Huang WQ. Distribution, cloning and sequencing of GnRH, its receptor, and effects of gastric acid secretion of GnRH analogue in gastric parietal cells of rats. Life Sci 2005;76:1351-65.
23. Gama P, Alvares EP. LHRH and somatostatin effects on the cell proliferation of the gastric epithelium of suckling and weaning rats. Regul Pept 1996;63:73-8. (Pubitemid 26239924)
24. Aguilar-Rojas A, Huerta-Reyes M. Human gonadotropinreleasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (Review). Oncol Rep 2009;22:981-90.
25. Khanna R, Browne RM, Heiner AD, Clench MH, Mathias Jr. Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy. Am J Physiol 1992; 262(1 Pt 1):G185-90.
26. Mathias JR, Baskin GS, Reeves-Darby VG, Clench MH, Smith LL, Calhoon JH. Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate. Dig Dis Sci 1992;37:1761-8.
27. Mathias JR, Clench MH, Reeves-Darby VG, Fox LM, Hsu PH, Roberts PH, et al. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci 1994; 39:1155-62. (Pubitemid 24190250)
28. Palomba S, Orio F Jr, Manguso F, Russo T, Falbo A, Lombardi G, et al. Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. Fertil Steril 2005;83:1012-20.
29. Rabin D, McNeil LW. Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. J Clin Endocrinol Metab 1980;51:873-6. (Pubitemid 10024747)
30. Wang F, Zheng TZ, Li W, Qu SY, He DY. Action of progesterone on contractile activity of isolated gastric strips in rats. World J Gastroenterol 2003;9:775-8. (Pubitemid 36531559)
31. Mathias JR, Clench MH. Relationship of reproductive hormones and neuromuscular disease of the gastrointestinal tract. Dig Dis 1998;16:3-13. (Pubitemid 128527697)
32. Sennello LT, Finley RA, Chu SY, Jagst C, Max D, Rollins DE, et al. Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration. J Pharm Sci 1986;75:158-60. (Pubitemid 16125665)
33. Holland FJ, Fishman L, Costigan DC, Luna L, Leeder S. Pharmacokinetic characteristics of the gonadotropinreleasing hormone analog D-Ser(TBU)-6EA- 10luteinizing hormone-releasing hormone (buserelin) after subcutaneous and intranasal administration in children with central precocious puberty. J Clin Endocrinol Metab 1986;63: 1065-70. (Pubitemid 17173038)
34. Lindner J, McNeil LW, Marney S, Conway M, Rivier J, Vale W, et al. Characterization of human anti-luteinizing hormone-releasing hormone (LRH) antibodies in the serum of a patient with isolated gonadotropin deficiency treated with synthetic LRH. J Clin Endocrinol Metab 1981;52: 267-70. (Pubitemid 11183623)
35. Ahmed MN, Carpenter S. Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J 1975;113: 410-12.
36. Bell CE Jr, Seetharam S. Expression of endodermally derived and neural crest-derived differentiation antigens by human lung and colon tumors. Cancer 1979;44:13-18. (Pubitemid 9234902)
37. Schuffler MD, Baird HW, Fleming CR, Bell CE, Bouldin TW, Malagelada JR, et al. Intestinal pseudoobstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med 1983;98:129-34. (Pubitemid 13190906)
38. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 1986;80: 45-52. (Pubitemid 16134802)
39. De Giorgio R, Bovara M, Barbara G, Canossa M, Sarnelli G, De Ponti F, et al. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 2003;125:70-9. (Pubitemid 36799108)
40. Stephansson O, Kieler H, Granath F, Falconer H. Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod 2009;24:2341-7.
41. Remorgida V, Ragni N, Ferrero S, Anserini P, Torelli P, Fulcheri E. The involvement of the interstitial Cajal cells and the enteric nervous system in bowel endometriosis. Hum Reprod 2005;20:264-71.